|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
s in Sensitization of AC1
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana (T.A.V, C.H.N., V.J.W.); and Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania (C.H.B.)
Short-term activation of G
i/o-coupled receptors inhibits adenylyl cyclase, whereas persistent activation of G
i/o-coupled receptors results in a compensatory sensitization of adenylyl cyclase activity after subsequent activation by G
s or forskolin. Several indirect observations have suggested the involvement of increased G
s-adenylyl cyclase interactions in the expression of sensitization; however, evidence supporting a direct role for G
s has not been well established. In the present report, we used two genetic approaches to further examine the role of G
s in heterologous sensitization of Ca2+-sensitive type 1 adenylyl cyclase (AC1). In the first approach, we constructed G
s-insensitive mutants of AC1 (F293L and Y973S) that retained sensitivity to Ca2+ and forskolin activation. Persistent (2 h) activation of the D2 dopamine receptor resulted in a significant augmentation of basal or Ca2+- and forskolin-stimulated AC1 activity; however, sensitization of G
s-insensitive mutants of AC1 was markedly reduced compared with wild-type AC1. In the second strategy, we examined the requirement of an intact receptor-G
s signaling pathway for the expression of sensitization using dominant-negative G
s mutants (
3
5 G226A/A366S or
3
5 G226A/E268A/A366S) to disrupt D1 dopamine receptor activation of recombinant AC1. D1 dopamine receptor-G
s signaling was attenuated in the presence of
3
5 G226A/A366S or
3
5 G226A/E268A/A366S, but D2 agonist-induced sensitization of Ca2+-stimulated AC1 activity was not altered. Together, the present findings directly support the hypothesis that the expression of sensitization of AC1 involves G
s-adenylyl cyclase interactions.
Address correspondence to: Dr. Val J. Watts, Purdue University, Medicinal Chemistry and Molecular Pharmacology, 575 Stadium Mall Dr., RHPH 224A West Lafayette, IN 47907. E-mail: wattsv{at}pharmacy.purdue.edu